DNase1 genotypes were determined, and plasma markers of NETosis (elastase, MPO, cfDNA) were quantified
Impaired activity of methionine synthase results in elevated blood concentrations of homocysteine, while impaired activity of L-methylmalonyl-CoA mutase results in increased concentrations of a metabolite of methylmalonyl-CoA called methylmalonic acid (MMA) in blood and urine
Interestingly, aged mice exhibited a re-emergence of several youthful phenotypic traits following treatmentincluding increased physical activity, improved cognitive performance, and enhanced fur density
However, it remains a preclinical compound: unapproved by the FDA, prohibited under WADAs Schedule 0 category, and without a single completed, published human trial
The mechanism and timeline are the same as for male patients, with some adjustments in the protocol for patients in perimenopause or menopause where hormonal changes affect collagen synthesis and healing rates